News

The Department of Health and Human Services moved to eliminate thimerosal from flu shots in a victory for antivaccine ...
The federal government is recommending flu vaccines remove the preservative thimerosal after Health and Human Services ...
Sanofi has signed an agreement to acquire UK-based biotechnology company Vicebio’s share capital for $1.15bn upfront, to expand its vaccine development capabilities. The deal also includes additional ...
While few shots still contain thimerosal, the move eliminates a vaccine option for Americans and is a win for the ...
Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...
Paris-based drugmaker Sanofi is acquiring U,K,-based Vicebio to gain its molecular clamp vaccine technology, with the total ...
Sanofi has announced that it will be expanding its respiratory vaccines pipeline by acquiring UK-based Vicebio for up to ...